Multiple banks are competing to join a $4.25 billion debt financing backing Curium’s acquisition of radiopharmaceutical company Lantheus Holdings Inc., before the deal is syndicated to investors next year.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.